Nipro completes trial enrollment: what it means for Nipro stock

Published on 10/07/2026 at 04:05 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

The Golazo trial reached enrollment completion on October 1, 2026. Nipro stock has a JPY 219.7 billion market value as of October 7, 2026.

Nipro, JP3673600007, Illustration mit AI erstellt.

Nipro Corporation (ISIN JP3673600007) had a JPY 219.7 billion market capitalization as of October 7, 2026, after completing patient enrollment in the GREAT U.S. pivotal trial for its Golazo peripheral atherectomy system on October 1, 2026. The company said the milestone in its investor-relations release, placing the device program at the center of the latest update for Nipro stock.

Trial enrollment reaches milestone

According to NIPRO CORPORATION on October 1, 2026, enrollment is complete in the GREAT U.S. pivotal trial evaluating the Golazo peripheral atherectomy system. The announcement moves the program from recruitment toward the next stages of clinical and regulatory work, although the enrollment milestone itself does not establish a product approval date.

Golazo is part of Nipro's medical-technology portfolio, which also includes dialysis and other healthcare products. For investors, the key distinction is between a completed trial milestone and a commercial launch, because the former provides a development update while the latter would create a direct sales catalyst.

Balance sheet gets a capital boost

Nipro also completed the conversion of JPY 29.93 billion of 2026-maturity euro-yen convertible bonds, representing 99.80 percent of the total issue, according to Japan IR on September 15, 2026. The company redeemed JPY 70.00 million at maturity on September 25, 2026.

The conversion involved 20,930,064 shares. Nipro said the transaction reduced interest-bearing debt and strengthened equity, giving the trial update a parallel capital-structure angle rather than leaving the story dependent on clinical progress alone.

Stock context stays measured

Nipro's Tokyo Stock Exchange ticker is 8086, and a master-data listing identifies the security as JP3673600007, according to MarketScreener. The finance quote for October 7, 2026 showed a JPY 1,292.50 to JPY 1,760.50 52-week range, putting the latest JPY 1,347.00 quote inside that band and JPY 413.50 below the high.

The Lang & Schwarz prior close was EUR 7.50 on October 5, 2026. The further course of trading is shown by the continuously updated real-time quote of Nipro stock.